Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Favorable regulatory scenario
3.2.1.2 Rising awareness among women regarding various IUD applications
3.2.1.3 High number of unintended pregnancies
3.2.1.4 Government initiatives for the prevention of unwanted abortions and pregnancies
3.2.1.5 Growing inclination towards planned delayed pregnancy
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of device
3.2.2.2 Risk of several health issues
3.2.2.3 Variability in insurance coverage and access
3.3 Growth potential analysis
3.4 Technology landscape
3.5 U.S. intrauterine device units sold, by brand, 2021 -2032
3.6 Future market trends
3.7 Regulatory landscape
3.8 Reimbursement scenario
3.9 Gap analysis
3.10 Porter’s analysis
3.11 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Company market share analysis
4.5 Company positioning matrix
4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Copper IUD
5.3 Hormonal IUD
Chapter 6 Market Estimates and Forecast, By Age Group, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 15-19
6.3 20-24
6.4 25-29
6.5 30-34
6.6 35-39
6.7 40-44
6.8 45+
Chapter 7 Market Estimates and Forecast, By End-use, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Hospitals
7.3 Gynecology clinics
7.4 Community health care centers
Chapter 8 Market Estimates and Forecast, By Zone, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 East North Central
8.2.1 Illinois
8.2.2 Indiana
8.2.3 Michigan
8.2.4 Ohio
8.2.5 Wisconsin
8.3 West South Central
8.3.1 Arkansas
8.3.2 Louisiana
8.3.3 Oklahoma
8.3.4 Texas
8.4 South Atlantic
8.4.1 Delaware
8.4.2 Florida
8.4.3 Georgia
8.4.4 Maryland
8.4.5 North Carolina
8.4.6 South Carolina
8.4.7 Virginia
8.4.8 West Virginia
8.4.9 Washington, D.C.
8.5 Northeast
8.5.1 Connecticut
8.5.2 Maine
8.5.3 Massachusetts
8.5.4 New Hampshire
8.5.5 Rhode Island
8.5.6 Vermont
8.5.7 New Jersey
8.5.8 New York
8.5.9 Pennsylvania
8.6 East South Central
8.6.1 Alabama
8.6.2 Kentucky
8.6.3 Mississippi
8.6.4 Tennessee
8.7 West North Central
8.7.1 Iowa
8.7.2 Kansas
8.7.3 Minnesota
8.7.4 Missouri
8.7.5 Nebraska
8.7.6 North Dakota
8.7.7 South Dakota
8.8 Pacific Central
8.8.1 Alaska
8.8.2 California
8.8.3 Hawaii
8.8.4 Oregon
8.8.5 Washington
8.9 Mountain States
8.9.1 Arizona
8.9.2 Colorado
8.9.3 Utah
8.9.4 Nevada
8.9.5 New Mexico
8.9.6 Idaho
8.9.7 Montana
8.9.8 Wyoming
Chapter 9 Company Profiles
9.1 Allergan (AbbVie Inc.)
9.2 Bayer AG
9.3 CooperSurgical Inc.
9.4 Durbin
9.5 Meril Life Sciences Pvt. Ltd.
9.6 Mylan N.V. (Viatris)
9.7 Pregna International Ltd.
9.8 SMB Corporation of India
